Raskin - Chapter 10

A type of hormone responsible for the development of male characteristics; testosterone is the most well-known androgen.

ICD-11 diagnosis for men and women who experience absent, infrequent, or diminished orgasms; also called orgasmic dysfunction, its name in ICD-10.

Drugs that reduce levels of male sex hormones such as testosterone, thereby decreasing sexual interest.

People who are attracted to both sexes.

Use of antiandrogens to bring testosterone levels as low as those found in people who have been surgically castrated.

Term for people whose gender identity and birth sex match.

Nonheterosexual people who have yet to come out.

ICD-11 paraphilic disorder characterized by fantasies, urges and behaviors involving physically or psychologically imposing harm on nonconsenting others.

Process by which people come to accept and declare their sexual orientation or gender identity to others.

An ICD-11 impulse control disorder diagnosable in people who seem unable to control their sexual appetites.

Therapy to turn homosexuals into heterosexuals; popular in the past, but almost universally rejected today as unethical.

Aversion therapy in which an unpleasant image is presented (in vivo or imaginally) while the client focuses on the paraphilic interest; the goal is to associate the paraphilic interest with the unpleasant image in order to lessen the behavior.

Prescription of sex hormones (androgens, estrogens, and antiandrogens) to alter people’s physical appearance as they transition from one sex to the other; also called hormone therapy.

DSM-5 diagnosis for men who show a delay in (or inability to) ejaculate despite being stimulated and wanting to ejaculate more quickly.

ICD-10 diagnosis for women and men who experience pain during intercourse—sometimes with no physical basis and other times with evidence of psychological factors (such as past sexual abuse); also in ICD-11, where it must have physical determinants.